Pertussin-Ch (Pertussin-C)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceThyme creeping herb extract + [Potassium bromide]Thyme creeping herb extract + [Potassium bromide]
Similar drugsTo uncover
  • Pertussin
    syrup inwards 
    FLORA CAUCASUS, OJSC     Russia
  • Pertussin
    syrup
    SAMARAHEDPROM, JSC     Russia
  • Pertussin-Ch
    syrup inwards 
    IVANOVSKAYA Pharmaceutical Factory, OAO     Russia
  • Pertussin-Ch
    syrup inwards 
    PHARMACEUTICAL FACTORY (ASTRAKHAN), OJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    YAROSLAVSK PHARMACEUTICAL FACTORY, CJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    Pharmaceutical Company Kopeisk, OJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    PERMFARMACY, OJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    TVERSKAYA PHARMACEUTICAL FACTORY, OJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    MOSCOW PHARMACEUTICAL FACTORY, CJSC     Russia
  • Pertussin-Ch
    syrup inwards 
    ROSTOVSKAYA FARMFABRIKA, CJSC     Russia
    • Dosage form: & nbspsyrup
    Composition:
    Ingredients per 100 g:
    Active substances:
    Thyme extract liquid - 12.0 g Potassium bromide - 1.0 g Excipients:
    Sucrose solution 64% (sugar syrup) - 82.0 g Ethanol (ethyl alcohol) 95% - 4.06 g Purified water - 0.94 g
    Description:
    a thick liquid of brown color with a fragrant smell.

    Pharmacotherapeutic group:expectorant
    ATX: & nbsp

    R.05.C.A   Expectorants

    Pharmacodynamics:
    Combined drug. The herb extract of thyme exerts an expectorant effect,increases the amount of secretory detachable mucous membranes of the upper respiratory tract, contributes to the liquefaction of sputum and acceleration of its evacuation. Potassium bromide reduces the excitability of the central nervous system.

    Indications:
    As an expectorant in the complex therapy of acute respiratory diseases; tracheitis, bronchitis, and also with whooping cough.

    Contraindications:
    Hypersensitivity to the drug components, liver disease, alcoholism, craniocerebral trauma, brain diseases, epilepsy, chronic heart failure (in decompensation stage), pregnancy, lactation period, children's age (up to 3 years).

    Carefully:
    diabetes; children age over 3 years (due to the presence of ethanol in the drug).

    Dosing and Administration:
    The drug is taken orally, after a meal (due to the possibility of reducing appetite).
    Adults take 1 tablespoon 3 times a day;
    children from 3 to 6 years - 1 / 2-1 teaspoon 3 times a day;
    children from 6 to 12 years - 1-2 teaspoons 3 times a day;
    children over 12 years - 1 dessert spoon 3 times a day.
    The course of treatment is 10-14 days. An increase in the duration and conduct of repeated courses of treatment is possible on the recommendation of a doctor.

    Side effects:
    Allergic reactions, heartburn are possible.

    Overdose:
    In case of an overdose of the drug, nausea is possible.
    Treatment: symptomatic.

    Interaction:
    The drug should not be used simultaneously with antitussive drugs, as this makes it difficult to cough up thinned phlegm.

    Special instructions:
    The drug contains 8-11% ethanol. The content of absolute alcohol is: in 1 teaspoonful (5 ml) - up to 0.43 g, in 1 dessert spoon (10 ml) - up to 0.87 g, in 1 tablespoon (15 ml) - up to 1.3 g. In the maximum daily dose of the drug for adults - 3 tablespoons (45 ml) - contains up to 3.9 grams of absolute alcohol.
    During the treatment period, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require increased attention and speed of psychomotor reactions.
    Indication for patients with diabetes: the content of sucrose in 1 teaspoon (5 ml) of the drug corresponds to approximately 0.22 XE, in 1 dessert spoon (i 0 ml) - about 0.44 XE; in 1 tablespoon - about 0.66 XE.

    Effect on the ability to drive transp. cf. and fur:During the treatment period, care must be taken when driving vehicles and engaging in other potentially hazardous activities,requiring increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:
    Syrup.
    Packaging:
    For 100 g, 125 g of the drug in bottles of orange or brown glass, ukuporennyh caps aluminum with perforation or screw caps.
    Each bottle, together with the instructions for use, is placed in a pack of cardboard.
    It is allowed to pack vials without a pack together with an equal number of instructions for use in a group package.
    Storage conditions:
    In a dry place at a temperature of 12 to 15 ° C.
    Keep out of the reach of children.

    Shelf life:
    4 years.
    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-008022/09
    Date of registration:13.10.2009
    The owner of the registration certificate:MOSCOW PHARMACEUTICAL FACTORY, CJSC MOSCOW PHARMACEUTICAL FACTORY, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspMOSCOW PHARMACEUTICAL FACTORY MOSCOW PHARMACEUTICAL FACTORY Russia
    Information update date: & nbsp04.09.2015
    Illustrated instructions
      Instructions
      Up